Evidence map›Paper›PMID 28237819›Full record

ReviewTrends in endocrinology and metabolism: TEM2017

The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond.

Peter L Lee, Su Myung Jung, David A Guertin

Open access · greenAbstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Trial
  2. Article
  3. The insulin signalling network.Nature metabolism · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. mTORC1 in energy expenditure: consequences for obesity.Nature reviews. Endocrinology · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Peter L LeeProgram in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, MA 01605, USA.
Su Myung JungProgram in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, MA 01605, USA.
David A GuertinProgram in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, MA 01605, USA. Electronic address: david.guertin@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

Mechanistic Target of Rapamycin Pathways in Metabolism and Energy ExpenditureR01DK094004 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GUERTIN, DAVID A · 2013 to 2023
$4.5M
Elucidating the AKT-dependent and AKT-independent mechanisms of metabolic control by mTORC2R01CA196986 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GUERTIN, DAVID A · 2015 to 2019
$1.9M
Ethanol's Effects on Brown Adipose Development and FunctionF30AA024385 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEE, PETER LIN · 2015 to 2019
$148k
NCI NIH HHS R01 CA196986NIAAA NIH HHS F30 AA024385NIDDK NIH HHS R01 DK094004
6 · The paper itself

Abstract

Having healthy adipose tissue is essential for metabolic fitness. This is clear from the obesity epidemic, which is unveiling a myriad of comorbidities associated with excess adipose tissue including type 2 diabetes, cardiovascular disease, and cancer. Lipodystrophy also causes insulin resistance, emphasizing the importance of having a balanced amount of fat. In cells, the mechanistic target of rapamycin (mTOR) complexes 1 and 2 (mTORC1 and mTORC2, respectively) link nutrient and hormonal signaling with metabolism, and recent studies are shedding new light on their in vivo roles in adipocytes. In this review, we discuss how recent advances in adipose tissue and mTOR biology are converging to reveal new mechanisms that maintain healthy adipose tissue, and discuss ongoing mysteries of mTOR signaling, particularly for the less understood complex mTORC2.

Indexed as

AdipocytesAnimalsHumansInsulin ResistanceLipodystrophyMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Signal TransductionMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2

Identifiers

PMID28237819
PMCPMC5682923
OpenAlexW2589236941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.